News
Listen to this article Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...
Alex Kerr, UK economist at Capital Economics, said: “Based on the rise in gilt yields and the fall in interest rate ...
3h
HealthDay on MSNOne in 10 With Substance Use Disorder Report Past-Year HospitalizationsAbout one in 10 U.S. adults with substance use disorder (SUD) report past-year hospitalizations, according to a research ...
AstraZeneca Pharmaceuticals LP and a Christian sales specialist have agreed to settle his suit over the company’s failure to ...
Donald Trump has paused his tariff onslaught for 90 days in a major climbdown he blamed on people “getting a little bit ...
22h
NewsNation on MSNAstraZeneca’s pill cuts cholesterol, offers convenient treatmentAstraZeneca’s experimental pill has shown promise in reducing “bad” cholesterol, raising expectations for more convenient ...
EUROPEAN shares tumbled further on Wednesday as China more than doubled its tariffs on US imports, with healthcare stocks ...
Trump said overnight that the US would soon introduce a 'major tariff' on pharmaceuticals to force firms to relocate medicine production to America.
Trump says countries who were facing higher tariffs will now fall to the "baseline" tariff of 10% for at least 90 days.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results